[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1990

The Use of the Markov Process in Describing the Natural Course of Diabetic Retinopathy

Author Affiliations

From the Departments of Pediatrics (Drs Garg and Chase and Mr Crews), Ophthalmology (Dr Jackson), and Preventive Medicine and Biometrics (Dr Archer and Mr Marshall), Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver.

Arch Ophthalmol. 1990;108(9):1245-1247. doi:10.1001/archopht.1990.01070110061025
Abstract

• The natural course of early diabetic retinopathy in young subjects with insulin-dependent diabetes mellitus was evaluated during 693 patient visits for 259 subjects during a mean of 2.4 years. Diabetic retinopathy is considered a progressive disease among people with insulin-dependent diabetes mellitus (type I). Improvement of early retinopathy has not been recognized as a part of the natural course. In our experience, 25% of observations in subjects with early diabetic retinopathy (grades 2 and 3) showed improvement. Thus, 28 of 174 observations of diabetic retinopathy improved from grade 2 to grade 1, and 34 of 79 observations improved from grade 3 to grades 2 or 1. Markov chains indicate that 25% of observations of diabetic retinopathy will change from grade 1 to grade 5 or 6 in 17.0 years and 25% will change from grade 2 to grade 5 or 6 in 16.0 years. Future studies of diabetic retinopathy should consider a matrix of estimated transition probabilities, depending on the population, to judge probabilities of transition between states of retinopathy.

References
1.
Klein R, Klein BEK.  Vision disorders in diabetes . In: Diabetes in America . Bethesda, Md: National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases; 1985:1-36. US Dept of Health and Human Services publication NIH 85-1468.
2.
Solerte SB, Ferrari E.  Diabetic retinal vascular complications and erythrocyte filterability: results of a 2 year follow-up study with pentoxifylline . Pharmatherapeutica . 1985;4:341-349.
3.
Kelly TM, Sanborn GE, Haug PJ, Edwards CQ.  Effect of insulin infusion pump use on diabetic retinopathy . Arch Ophthalmol . 1984;102:1156-1159.Article
4.
Puklin JE, Tamborlane WV, Felig P.  Genel M, Sherwin RS. Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy . Ophthalmology . 1982;89:735-747.Article
5.
Diabetic Retinopathy Study Research Group.  A modification of the Airlie House classification of diabetic retinopathy: report 7 . Invest Ophthalmol Vis Sci . 1981;21:210-226.
6.
Klein BEK, Davis MD, Segal P, et al.  Diabetic retinopathy: assessment of severity and progression . Ophthalmology . 1984;91:10-17.Article
7.
Kemeny JG, Snell JL. Finite Markov Chains . New York, NY: Van Nostrand Reinhold Co; 1960:24-38.
8.
Kay R.  A Markov model for analyzing cancer markers and disease state in survival studies . Biometrics . 1986;42:855-865.Article
9.
Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D.  Glucose control and the renal and retinal complications of insulin-dependent diabetes . JAMA . 1989;261:1155-1160.Article
10.
Klein R, Klein BEK, Moss SE, et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy . JAMA . 1988;260:2864-2871.Article
11.
Job D, Eschwege E, Guyot-Argenton C, Aubry J-P, Tchobroutsky G.  Effect of multiple daily insulin injections on the course of diabetic retinopathy . Diabetes . 1976;25:463-469.Article
12.
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T.  Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes . Lancet . 1983;1:200-204.Article
13.
Tamborlane WV, Puklin JE, Bergman M, et al.  Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy . Diabetes Care . 1982;5:58-64.
14.
Holman RR, Dornan TL, Mayon-White V.  Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two-year randomized prospective study . Lancet . 1983;2:204-208.Article
15.
The Kroc Collaborative Study Group.  Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multi-center trial . N Engl J Med . 1984;311:365-372.Article
16.
The DCCT Research Group.  Diabetes control and complications trial: results of feasibility study . Diabetes Care . 1978;10:10-19.
17.
Chase HP, Garg SK, Jackson WE, et al.  Blood pressure and retinopathy in type I diabetes . Ophthalmology . 1990;97:155-159.Article
18.
The DAMAD Study Group.  Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy . Diabetes . 1989;38:491-498.Article
19.
Pagani A, Greco G, Tagliaferro S, Marena S, Pagano G.  Dipyridamole administration in insulin-dependent diabetics with background retinopathy: a 36-month follow-up . Curr Ther Res . 1989;45:469-475.
20.
Groop LC, Tier H, Koskimies S, et al.  Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes . Diabetes . 1986;35:1397-1403.Article
21.
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years . Arch Ophthalmol . 1989;107:237-243.Article
22.
Kostraba JN, Dorman JS, Orchard TJ, et al.  Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects . Diabetes Care . 1989;12:686-693.Article
×